|
2-(2-(4-chlorophenoxy)ethoxy)-5,7-dimethyl-(1,2,4)triazolo(1,5-a)pyrimidine
|
C000601055 |
|
|
alpha3-fucosyltransferase V
|
C418611 |
|
|
Sick Role
|
D012803 |
[Set of expectations that exempt persons from responsibility for their illness and exempt them from usual responsibilities.
] |
|
4-((4-fluoro-2-isopropoxyphenyl)amino)-5-methylthieno(2,3-d)pyrimidine-6-carboxylic acid
|
C000601056 |
|
|
PHIP protein, human
|
C418612 |
|
|
Sick Sinus Syndrome
|
D012804 |
[A condition caused by dysfunctions related to the SINOATRIAL NODE including impulse generation (CARDIAC SINUS ARREST) and impulse conduction (SINOATRIAL EXIT BLOCK). It is characterized by persistent BRADYCARDIA, chronic ATRIAL FIBRILLATION, and failure to resume sinus rhythm following CARDIOVERSION. This syndrome can be congenital or acquired, particularly after surgical correction for heart defects.
] |
|
4-((4-fluoro-2-isopropoxyphenyl)amino)-N-(2-methoxyethyl)-5-methylthieno(2,3-d)pyrimidine-6-carboxamide
|
C000601057 |
|
|
phenyl thioketone
|
C000601058 |
|
|
(E)-8-acetoxy-2-(2-(3,4-diacetoxyphenyl)ethenyl)quinazoline
|
C000615691 |
|
|
EPDR1 protein, human
|
C000615692 |
|
|
4',6-dimethoxyisoflavone-7-O-beta-D-glucopyranoside
|
C000615693 |
|
|
plicosepalin A
|
C000615694 |
|
|
penicilloitin A
|
C000615695 |
|
|
N-(4-isothiocyanatobenzyl)-2-(3-(tributylstannyl)phenyl)acetamide
|
C000615696 |
|
|
5,10,15,20-tetrakis(5-(pyrrolidin-1-yl)pentyl)porphin
|
C000615697 |
|
|
3-nitrophthalic acid
|
C000615698 |
|
|
fhx protein, Bombyx mori
|
C418613 |
|
|
Signs and Symptoms
|
D012816 |
[Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.
] |
|
camphecene
|
C000615699 |
|
|
LOC100310874 protein, rat
|
C418614 |
|
